Brief: Brainstorm Cell Therapeutics Data Show Treatment With NurOwn Significantly Reduces NfL, A Key Biomarker Of Neurodegeneration
07/07/2023 12:09
July 7 (Reuters) - Brainstorm Cell Therapeutics Inc
BCLI.O :
* BRAINSTORM CELL THERAPEUTICS DATA SHOW TREATMENT WITH
NUROWN
SIGNIFICANTLY REDUCES NFL, A KEY BIOMARKER OF NEURODEGENERATION
Source text for Eikon: ID:nPn1SBZ3ya
Further company coverage: BCLI.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Brainstorm Cell Therapeutics
See all newsBrief: Brainstorm Appoints Former FDA Associate Commissioner Peter J. Pitts As Executive Chairman
Brief: Brainstorm Cell Therapeutics Announces First Quarter 2026 Financial Results And Provides Corporate Update
Brief: Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing At Premium To Market
Brief: Brainstorm Cell Therapeutics Announces Second Quarter Financial Results
Brainstorm Cell Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview